-
Something wrong with this record ?
An in vitro bacterial adhesion assessment of surface-modified medical-grade PVC
A. Asadinezhad, I. Novák, M. Lehocký, V. Sedlarík, A. Vesel, I. Junkar, P. Sáha, I. Chodák,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Anti-Infective Agents pharmacology MeSH
- Bacterial Adhesion MeSH
- Benzalkonium Compounds chemistry MeSH
- Biofilms MeSH
- Biocompatible Materials chemistry MeSH
- Models, Chemical MeSH
- Chlorhexidine chemistry MeSH
- Escherichia coli metabolism MeSH
- Polyvinyl Chloride chemistry MeSH
- Surface Properties MeSH
- Propylene Glycols chemistry MeSH
- Drug Design MeSH
- Wettability MeSH
- Staphylococcus aureus metabolism MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Medical-grade polyvinyl chloride was surface modified by a multistep physicochemical approach to improve bacterial adhesion prevention properties. This was fulfilled via surface activation by diffuse coplanar surface barrier discharge plasma followed by radical graft copolymerization of acrylic acid through surface-initiated pathway to render a structured high density brush. Three known antibacterial agents, bronopol, benzalkonium chloride, and chlorhexidine, were then individually coated onto functionalized surface to induce biological properties. Various modern surface probe techniques were employed to explore the effects of the modification steps. In vitro bacterial adhesion and biofilm formation assay was performed. Escherichia coli strain was found to be more susceptible to modifications rather than Staphylococcus aureus as up to 85% reduction in adherence degree of the former was observed upon treating with above antibacterial agents, while only chlorhexidine could retard the adhesion of the latter by 50%. Also, plasma treated and graft copolymerized samples were remarkably effective to diminish the adherence of E. coli.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12026459
- 003
- CZ-PrNML
- 005
- 20130117121932.0
- 007
- ta
- 008
- 120817e20100211ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.colsurfb.2010.02.006 $2 doi
- 035 __
- $a (PubMed)20189783
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Asadinezhad, Ahmad $u Polymer Centre, Faculty of Technology, Tomas Bata University in Zlín, T.G.M. Sq. 275, 762 72 Zlín, Czech Republic. $7 gn_A_00009156
- 245 13
- $a An in vitro bacterial adhesion assessment of surface-modified medical-grade PVC / $c A. Asadinezhad, I. Novák, M. Lehocký, V. Sedlarík, A. Vesel, I. Junkar, P. Sáha, I. Chodák,
- 520 9_
- $a Medical-grade polyvinyl chloride was surface modified by a multistep physicochemical approach to improve bacterial adhesion prevention properties. This was fulfilled via surface activation by diffuse coplanar surface barrier discharge plasma followed by radical graft copolymerization of acrylic acid through surface-initiated pathway to render a structured high density brush. Three known antibacterial agents, bronopol, benzalkonium chloride, and chlorhexidine, were then individually coated onto functionalized surface to induce biological properties. Various modern surface probe techniques were employed to explore the effects of the modification steps. In vitro bacterial adhesion and biofilm formation assay was performed. Escherichia coli strain was found to be more susceptible to modifications rather than Staphylococcus aureus as up to 85% reduction in adherence degree of the former was observed upon treating with above antibacterial agents, while only chlorhexidine could retard the adhesion of the latter by 50%. Also, plasma treated and graft copolymerized samples were remarkably effective to diminish the adherence of E. coli.
- 650 _2
- $a antiinfekční látky $x farmakologie $7 D000890
- 650 _2
- $a bakteriální adheze $7 D001422
- 650 _2
- $a benzalkoniové sloučeniny $x chemie $7 D001548
- 650 _2
- $a biokompatibilní materiály $x chemie $7 D001672
- 650 _2
- $a biofilmy $7 D018441
- 650 _2
- $a chlorhexidin $x chemie $7 D002710
- 650 _2
- $a racionální návrh léčiv $7 D015195
- 650 _2
- $a Escherichia coli $x metabolismus $7 D004926
- 650 _2
- $a chemické modely $7 D008956
- 650 _2
- $a polyvinylchlorid $x chemie $7 D011143
- 650 _2
- $a propylenglykoly $x chemie $7 D011409
- 650 _2
- $a Staphylococcus aureus $x metabolismus $7 D013211
- 650 _2
- $a povrchové vlastnosti $7 D013499
- 650 _2
- $a smáčivost $7 D017155
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Novák, Igor
- 700 1_
- $a Lehocký, Marián
- 700 1_
- $a Sedlarík, Vladimir
- 700 1_
- $a Vesel, Alenka
- 700 1_
- $a Junkar, Ita
- 700 1_
- $a Sáha, Petr
- 700 1_
- $a Chodák, Ivan
- 773 0_
- $w MED00180202 $t Colloids and surfaces. B, Biointerfaces $x 1873-4367 $g Roč. 77, č. 2 (20100211), s. 246-56
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20189783 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20130117122045 $b ABA008
- 999 __
- $a ok $b bmc $g 948501 $s 783805
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 77 $c 2 $d 246-56 $e 20100211 $i 1873-4367 $m Colloids and surfaces. B, Biointerfaces $n Colloids surf., B Biointerfaces $x MED00180202
- LZP __
- $a Pubmed-20120817/10/04